
Global Companion Animal Postoperative Pain Management Therapeutics Market, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
15840
May 2023
178
“Global Companion Animal Postoperative Pain Management Therapeutics Market” is an upcoming market research report by MarketResearch.biz. Critical data and information regarding the global companion animal postoperative pain management therapeutics market are included in the report in detail such as market drivers, trends, restraints, market growth opportunities, competitive landscape, details of key players, etc. The global companion animal postoperative pain management therapeutics market research report is segmented on the basis of product, animal type, and regions and countries.
Overview
Veterinary pain management is an important part of veterinary therapeutics. Due to not addressing pain appropriately in animals, healing can be delayed. The cause of pain in animals can be due to arthritis, cancer, and surgeries. Pain in animals can be accompanied by aggression, loss of appetite, and reduced activity. This can affect the productivity of pets and farm animals. There are multiple options available for treating different causes of pain in animals such as physical rehabilitation, pain medications, therapeutic massage, laser therapy, and acupuncture. Researches are also ongoing to introduce more options to lower the pain in animals due to injuries, sickness, and surgeries.
Dynamics
One among some of the key factors driving growth of the global companion animal postoperative pain management therapeutics market is increasing pet surgical procedures, especially dental and orthopedic surgeries. Rising prevalence of periodontal diseases is projected to fuel demand for dental surgeries. Increasing companion animal ownership is also projected to further drive revenue growth. Another factor expected to drive growth of the global companion animal postoperative pain management therapeutics market is increasing disposable income in both developed and developing countries. Increasing adoption of NSAIDs owing to restricted use of opioids and rising concerns among pet owners are projected to drive growth of the market over the forecast period. Factors such as increasing number of pet clinics and veterinary hospitals are positively affecting the global companion animal postoperative pain management therapeutics market growth. The global market is projected to grow further due to increasing awareness of pet owners regarding providing animal care and high-class healthcare to their pets. In addition, governments are also taking initiatives to spread awareness regarding the same, which is expected to drive overall development of the global companion animal postoperative pain management therapeutics market over the forecast period.
Global Companion Animal Postoperative Pain Management Therapeutics Market Segment Analysis:
By Product: The NSAIDs segment continues to account for highest revenue share in the global companion animal postoperative pain management therapeutics market among other product segments. This dominance is expected to continue over the forecast period. This growth of the segment can be attributed to the easy availability of the product. NSAIDs are more affordable compared to opioids and anesthetics, which is expected to fuel revenue growth. The anesthetics segment among the product segments is expected to register a steady growth over the forecast period.
By Animal Type: The canine segment among the animal type segments is projected to continue its dominance in terms of revenue share. This dominance is expected to continue over the forecast period. This growth of the segment can be attributed to rising incidence of chronic diseases in dogs. Hip dysplasia, dental, cataract, neutering, and wound repair are some of the most common surgeries, which are performed on dogs and require postoperative care. In addition, growing adoption of dogs in developing and developed countries as companion animals among households is attributed to this growth of the segment.
Global Companion Animal Postoperative Pain Management Therapeutics Market Regional Analysis:
The North American regional market accounts for highest revenue share currently in the global companion animal postoperative pain management therapeutics market, which is expected to continue over the forecast period. This can be attributed to increasing government initiatives and favorable healthcare structure in the region. In addition, increasing pet ownership and growing demand for effective animal care in the region is projected to create revenue generation opportunities. Also, rising number of veterinary surgeries, especially dental and orthopedic surgeries, is attributed to growth of the market in the region.
Global Companion Animal Postoperative Pain Management Therapeutics Market Segmentation:
By Product:
- NSAIDs
- Anesthetics
- Opioids
- Others
By Animal Type:
- Canine
- Feline
By Region:
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
- Zoetis
- Bayer AG
- Elanco
- Ceva
- Norbrook
- Dechra Pharmaceuticals
- Merck Animal Health
Request for TOC
Inquiry Form
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!